Enfusion, Inc. (NYSE:ENFN – Free Report) was the target of a significant decrease in short interest during the month of June. As of June 15th, there was short interest totalling 1,000,000 shares, a decrease of 21.9% from the May 31st total of 1,280,000 shares. Based on an average daily trading volume, of 454,100 shares, the […]
Enfusion, Inc. (NYSE:ENFN – Get Rating) saw strong trading volume on Wednesday . 894,371 shares were traded during trading, an increase of 122% from the previous session’s volume of 402,557 shares.The stock last traded at $7.99 and had previously closed at $7.73. Wall Street Analysts Forecast Growth A number of equities research analysts recently issued […]
Shares of Enfusion, Inc. (NYSE:ENFN – Get Rating) reached a new 52-week low on Monday after an insider sold shares in the company. The company traded as low as $7.77 and last traded at $7.97, with a volume of 59225 shares. The stock had previously closed at $8.07. Specifically, CTO Dan Groman sold 3,877 shares […]
Enfusion, Inc. (NYSE:ENFN – Get Rating) CTO Dan Groman sold 15,048 shares of the company’s stock in a transaction that occurred on Wednesday, May 10th. The stock was sold at an average price of $8.34, for a total value of $125,500.32. Following the sale, the chief technology officer now directly owns 79,809 shares of the […]
Enfusion (NYSE:ENFN – Get Rating) is scheduled to be issuing its quarterly earnings data before the market opens on Tuesday, May 9th. Analysts expect the company to announce earnings of $0.03 per share for the quarter. Individual interested in listening to the company’s earnings conference call can do so using this link. Enfusion (NYSE:ENFN – […]